placeholder image
B. W. Bode All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Glycaemic outcomes in adults with type 2 diabetes over 34鈥墂eeks with the Omnipod庐 5 Automated Insulin Delivery System. 
    Diabetes, Obesity & Metabolism. 2025
  • Safety and effectiveness of MiniMed鈩� 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2025
  • Glycemic outcomes persist for up to 2 years in very young children with the Omnipod(庐) 5 Automated Insulin Delivery System. 
    Diabetes Technology & Therapeutics. 2024
  • Psychosocial outcomes with the Omnipod庐 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes. 
    Diabetes, Obesity & Metabolism. 2024
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2024
  • Assessing time in range with postprandial glucose-focused titration of ultra rapid lispro (URLi) in people with type聽1 diabetes. 
    Diabetes Therapy. 2023
  • Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. 
    Diabetes Technology & Therapeutics. 2023
  • Safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes: from injections to hybrid closed-loop therapy. 
    Diabetes care. 2023
  • Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod庐 5 System. 
    Diabetes Research and Clinical Practice. 2022
  • Safety and glycemic outcomes during the MiniMed鈩� Advanced Hybrid Closed-Loop System Pivotal Trial in adolescents and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial. 
    Diabetes care. 2022
  • First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 
    Diabetes care. 2021
  • Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system. 
    Diabetes Technology & Therapeutics. 2021
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • Ultra-rapid lispro improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy. 
    Diabetes Technology & Therapeutics. 2020
  • Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: a multicentre, randomized controlled trial using continuous glucose monitoring. 
    Diabetes, Obesity & Metabolism. 2019
  • Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. 
    The lancet. Diabetes & endocrinology. 2017
  • Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1). 
    Diabetes care. 2017
  • Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2017
  • REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 
    Diabetes care. 2017
  • Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. 
    JAMA. 2016
  • Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes Randomized Clinical Trial. 
    JAMA. 2015
  • Predictors of hypoglycemia in the ASPIRE In-Home study and effects of automatic suspension of insulin delivery. 
    Journal of Diabetes Science and Technology. 2015
  • Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. 
    Diabetes care. 2015
  • Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. 
    Diabetes care. 2014
  • ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. 
    Journal of Diabetes Science and Technology. 2013
  • Threshold-based insulin-pump interruption for reduction of hypoglycemia. 
    New England Journal of Medicine. 2013
  • Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study. 
    Diabetes Technology & Therapeutics. 2012
  • Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. 
    Diabetes care. 2005
  • Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. 
    Diabetes care. 2005
    • Conference Poster
  • Improved glycemic control with carbohydrate counting for adjustment of fast-acting insulin aspart versus insulin aspart in subjects with type 1 diabetes [poster]
    2018
  • Pivotal trial of a hybrid closed-loop system in type 1 diabetes (T1D) [poster]
    2016
    • Abstract
  • First home evaluation of the Omnipod Horizon automated glucose control system at specific glucose targets in children with type 1 diabetes [abstract]. 
    Diabetes. 2020
  • Safety and glycemic outcomes of the MiniMed advanced hybrid closed-loop (AHCL) system in subjects with T1D [abstract]. 
    Diabetes. 2020
  • Ultra-Rapid Lispro (URLi) demonstrates similar time-in-target range to Humalog with the Medtronic MiniMed 670G Hybrid Closed-Loop System [abstract]. 
    Diabetes. 2020
  • Double-blind mealtime faster-acting insulin aspart vs. insulin aspart in basal-bolus improves glycemic control in T1D: the Onset 1 Trial [abstract #293-OR]. 
    Diabetes. 2016
    • Contact
    full name
  • B. W. Bode
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration